Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

PET/MRI

  • You have access
    Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
    Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso and Andreas Kjaer
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 354-359; DOI: https://doi.org/10.2967/jnumed.120.248120
  • Multimodal Imaging of 2-Cycle PRRT with <sup>177</sup>Lu-DOTA-JR11 and <sup>177</sup>Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model
    You have access
    Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model
    Jakob Albrecht, Samantha Exner, Carsten Grötzinger, Sonal Prasad, Frank Konietschke, Nicola Beindorff, Anja A. Kühl, Vikas Prasad, Winfried Brenner and Eva J. Koziolek
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.120.250274
  • You have access
    Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing
    Stephanie L. Pugh and Pedro Torres-Saavedra
    Journal of Nuclear Medicine February 19, 2021, jnumed.120.245654; DOI: https://doi.org/10.2967/jnumed.120.245654
  • You have access
    18F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET/CT as reference standard
    Martijn Vincent Verhagen, Leon J Menezes, Deena Neriman, Tom A Watson, Shonit Punwani, Stuart A Taylor, Ananth Shankar, Stephen Daw and Paul D Humphries
    Journal of Nuclear Medicine February 19, 2021, jnumed.120.260059; DOI: https://doi.org/10.2967/jnumed.120.260059
  • You have access
    Lymph node staging with a combined protocol of 18F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma
    Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougere, Sara Yvonne Brucker and Helmut Dittmann
    Journal of Nuclear Medicine January 28, 2021, jnumed.120.255919; DOI: https://doi.org/10.2967/jnumed.120.255919
  • You have access
    Predicting Gemcitabine Delivery by 18F-FAC PET in Murine Models of Pancreatic Cancer
    James Russell, Milan Grkovski, Isabella J. O’Donoghue, Teja M. Kalidindi, Nagavarakishore Pillarsetty, Eva M. Burnazi, Amanda Kulick, Amber Bahr, Qing Chang, H. Carl LeKaye, Elisa de Stanchina, Kenneth H. Yu and John L. Humm
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 195-200; DOI: https://doi.org/10.2967/jnumed.120.246926
  • You have access
    The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation
    Adam L. Kesner
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.260950; DOI: https://doi.org/10.2967/jnumed.120.260950
  • You have access
    Investigating Low-Dose Image Quality in Whole-Body Pediatric 18F-FDG Scans Using Time-of-Flight PET/MRI
    Jeffrey P. Schmall, Suleman Surti, Hansel J. Otero, Sabah Servaes, Joel S. Karp and Lisa J. States
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 123-130; DOI: https://doi.org/10.2967/jnumed.119.240127
  • You have access
    PET/MRI versus PET/CT for Whole-Body Staging
    Stephen K Gerard
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.256453; DOI: https://doi.org/10.2967/jnumed.120.256453
  • You have access
    First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma
    Lukas Kessler, Anna Melissa Schlitter, Markus Kroenke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon P Robinson, Cesare Orlandi, Michael Herz, Behrooz H Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber and Christoph Rischpler
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.248021; DOI: https://doi.org/10.2967/jnumed.120.248021

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire